the bashers keep mentioning 10k? Is that our new drug in phase 1 clinical trials? thanks
Will 10k replace O by 2017? If 10k is good maybe we will get buy ratings?
We have no CEO but I have heard other companies do well without one too.
We seem to have enough cash for phase 1 trials for 10k I am averaging down again.